Plain-English translation of NCT06286631 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a scoring tool — like a calculator — that helps doctors predict whether papillary thyroid cancer has spread to lymph nodes before surgery. The tool will be created by analyzing data from about 1,000 patients who already had thyroid surgery, then tested on 300 new patients to see how accurate it is.
Some thyroid cancer patients need surgery to remove lymph nodes, while others don't — but doctors can't always tell beforehand. This scoring tool aims to make that prediction more accurate, so patients get the right surgery without unnecessary procedures.
You likely qualify if…
You likely don't qualify if…
If you are in the past medical records group, researchers will review your existing surgery and test results from 2021–2023 — no new visits needed. If you are in the clinical validation group, doctors will use the new scoring tool to assess you before your planned thyroid surgery, then compare the tool's prediction to what they actually find during or after surgery.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Enrollment target
~800 participants
Started
May 2023
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
16 Years – 80 Years
Last updated on clinicaltrials.gov in February 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yang Liu, doctor
Second Affiliated Hospital of Xi'an Jiaotong University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.